CRBN and plasma cell myeloma: For instance, the E3 ligase cereblon (CRBN) has been used for the targeted treatment of different diseases by FDA-approved chemical inhibitors like thalidomide (multiple myeloma, graft-versus-host disease), lenalidomide (myelodysplastic syndrome, multiple myeloma), and pomalidomide (multiple myeloma) [62].